SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-090303
Filing Date
2016-03-25
Accepted
2016-03-25 11:45:18
Documents
3
Period of Report
2016-05-11
Effectiveness Date
2016-03-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A v435283_def14a.htm DEF 14A 709607
2 GRAPHIC tproxy1.jpg GRAPHIC 262303
3 GRAPHIC tproxy2.jpg GRAPHIC 65158
  Complete submission text file 0001144204-16-090303.txt   1161987
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 161529070
SIC: 2834 Pharmaceutical Preparations